Infant Formula and Related Trade Issues in The Context of The International Code

The Director-General’s report on infant and young child nutrition to the World Health Assembly in 1992 briefly considered the health implications of direct advertising of infant formula to the general public.1 It pointed out that, because of the hazards associated with using breast-milk substitutes, infant formula was no ordinary consumer product, but that, up to the age of four to six months, it should be treated more as a nutritional medicine that should be used with the advice and under the supervision of health workers.
World Health Organization, Nutrition for Health and Development, Geneva, Switzerland, June 2001.

A teljes dokumentum itt található.